TBV - low float china nutritional play with great earnings, plenty of cash, little debt, trading at PE under 15 while the industry is 4 times that. Even the typical discount for foreign risk should still give this higher PE on earnings. Growth is definitely there and was just trading at $8 and just given an upgrade to $12 (which would give it PE around 33). This is one of the nicer looking undervalued plays on paper I have seen in a long time.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.